| Application no. and date | 16710352.2 (espacenet) (Federated) (European Patent Register), 20160216 | | Patent/reg. no. and date | DK/EP 3258919, 20200115 | | Publication date | 20171227 | | Priority no. and date | US 201562117031 P, 20150217 | | EP pub. no. and date |
EP 3258919 20171227 | | Effective date | | | Applicant/owner | Amphastar Pharmaceuticals, Inc., 11570 Sixth Street Rancho Cucamonga, CA 91730, US | | Applicant ref. no. | SUNAS/M26742 | | Inventor | MANTRIPRAGADA, Sankaram B., c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis, Indiana 46206-6288, US,
PICHE, Claude A., c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis, Indiana 46206-6288, US,
VAN BETSBRUGGE, Jo Jan Filip, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/724 (2006.01) , A61K 38/26 (2006.01) , A61K 9/14 (2006.01) , A61P 3/00 (2006.01) | | Title | Næsepulverformulering til behandling af hypoglykæmi | | Int. application no. | US2016018003 | | Int. publication no. | WO2016133863 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
